Standout Papers

Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. m... 2007 2026 2013 2019 547
  1. Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION) (2007)
    J.‐H. Saurat, G Stingl et al. British Journal of Dermatology

Immediate Impact

5 from Science/Nature 73 standout
Sub-graph 1 of 20

Citing Papers

Crohn's disease
2024 Standout
Psoriasis
2021 Standout
15 intermediate papers

Works of A. Camez being referenced

Achievement of early deep remission predicts better long-term outcomes for adalimumab-treated patients with Crohn's disease
2011
Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)
2007 Standout

Author Peers

Author Last Decade Papers Cites
A. Camez 152 103 46 616 380 24 885
Bart Frederick 145 35 78 598 200 19 1.0k
Piet LCM van Riel 163 10 61 177 80 17 937
Veerle Vanvoorden 82 40 648 363 24 1.1k
X. Bordas 82 69 581 352 33 913
Francesca Bartoli 69 4 68 268 187 43 825
Suthesh Sivapalaratnam 173 105 123 113 77 29 1.1k
Cynthia Madden 83 27 552 344 20 794
Molla Huq 87 9 34 407 71 41 1.1k
Kavitha Goyal 35 112 806 377 22 1.0k
L Paolozzi 188 2 10 313 122 14 914

All Works

Loading papers...

Rankless by CCL
2026